Evidence map›Paper›PMID 28635375›Full record

Trial reportJournal of psychopharmacology (Oxford, England)2017

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.

Mark T Wagner, Michael C Mithoefer, Ann T Mithoefer, Rebecca K MacAulay, Lisa Jerome, Berra Yazar-Klosinski, Rick Doblin

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of psychopharmacology (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 3 pooled it
23.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 3 syntheses or guidelines pooled it, 159 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Effects of MDMA on attention to positive social cues and pleasantness of affective touch.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Trial
  9. Trial
  10. Review
  11. Article
  12. Article
  13. Review
  14. Decreased COCommunications psychology · 2025
    Article
  15. The METEMP protocol: Massed exposure therapy enhanced with MDMA for PTSD.Contemporary clinical trials communications · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Mark T Wagner1 Department of Neurology, Medical University of South Carolina, Charleston, USA.
Michael C Mithoefer2 Private Practice, Mount Pleasant, USA.
Ann T Mithoefer2 Private Practice, Mount Pleasant, USA.
Rebecca K MacAulay3 Department of Psychology, University of Maine, Orono, USA.
Lisa Jerome4 MAPS Public Benefit Corp (MPBC), Santa Cruz, USA.
Berra Yazar-Klosinski5 Multidisciplinary Association for Psychedelic Studies, Santa Cruz, USA.
Rick Doblin5 Multidisciplinary Association for Psychedelic Studies, Santa Cruz, USA.
Multidisciplinary Association for Psychedelic Studies · USMedical University of South Carolina · USPublic Service Electric and Gas (United States) · USUniversity of Maine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A growing body of research suggests that traumatic events lead to persisting personality change characterized by increased neuroticism. Relevantly, enduring improvements in Post-Traumatic Stress Disorder (PTSD) symptoms have been found in response to 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy. There is evidence that lasting changes in the personality feature of "openness" occur in response to hallucinogens, and that this may potentially act as a therapeutic mechanism of change. The present study investigated whether heightened Openness and decreased Neuroticism served as a mechanism of change within a randomized trial of MDMA-assisted psychotherapy for chronic, treatment-resistant PTSD. The Clinician-Administered PTSD Scale (CAPS) Global Scores and NEO PI-R Personality Inventory (NEO) Openness and Neuroticism Scales served as outcome measures. Results indicated that changes in Openness but not Neuroticism played a moderating role in the relationship between reduced PTSD symptoms and MDMA treatment. Following MDMA-assisted psychotherapy, increased Openness and decreased Neuroticism when comparing baseline personality traits with long-term follow-up traits also were found. These preliminary findings suggest that the effect of MDMA-assisted psychotherapy extends beyond specific PTSD symptomatology and fundamentally alters personality structure, resulting in long-term persisting personality change. Results are discussed in terms of possible mechanisms of psychotherapeutic change.

Indexed as

AdultCombined Modality TherapyFemaleHallucinogensHumansMaleNeuroticismN-Methyl-3,4-methylenedioxyamphetaminePersonality InventoryPsychotherapyStress Disorders, Post-TraumaticTreatment OutcomeYoung AdultHallucinogensN-Methyl-3,4-methylenedioxyamphetamineMDMANEO personalityopennesspharmacotherapyposttraumatic stress disorder (PTSD)psychotherapytreatment outcome

Identifiers

PMID28635375
PMCPMC5544120
OpenAlexW2716623847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.